Andrew Karter to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Andrew Karter has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.156
-
Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease. Am J Med. 2020 02; 133(2):200-206.
Score: 0.573
-
Use of the refill function through an online patient portal is associated with improved adherence to statins in an integrated health system. Med Care. 2014 Mar; 52(3):194-201.
Score: 0.394
-
Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
Score: 0.106
-
The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med. 2011 Dec; 26(12):1396-402.
Score: 0.082